Home
Explore NIH Technologies
Explore work by over 1,500 NIH researchers | Available for Licensing & Collaboration
News
Register to attend a free NCI webinar. Attendees will learn about a new a djuvanted subunit mucosal Covid-19 vaccine. Study results show that this new vaccine prevents SARS-CoV-2 transmission and infection. Most SARS-CoV-2 vaccines focus on delivering immunization through an intramuscular injection
NIH is dedicated to researching rare diseases and collaborating with partners to bring products for rare diseases to market, not only during Rare Disease Week but throughout the year. As a result of such work, on November 22, 2022, the U.S. Food and Drug Administration approved Hemgenix®, the world
Are you interested in making an impact on the improvement of global health? Are you interested in working in a dynamic organization that values its employees and offers work-life flexibility? The National Institute of Allergy and Infectious Diseases (NIAID), one of the largest Institutes at the
The Federal Laboratory Consortium for Technology Transfer (FLC) is honoring 32 FLC Award winners (three of whom are from NIH) from 8 federal agencies for their contributions to technology transfer, which turns cutting-edge research into impactful products and services. The FLC represents over 300
Explore Featured Research
Get updates on the latest and most exciting research coming out of NIH...
Explore Featured Products
Novel and interesting products coming to market through NIH inventions and partnerships...